Different Types of Progesterone in the Prevention of Preterm Labor
NCT03537287 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 140
Last updated 2018-05-29
Summary
Preterm birth is a common problem in obstetric care,with estimates ranging from 5% in several European countries to 18% in some African countries, Preterm labor defined as delivery before 37 completed weeks is the leading cause of perinatal and neonatal morbidity and mortality and strongly related to the developmental and neurological disabilities later in life..
There is still considerable uncertainty regarding the optimal progesterone type, route of administration, dosage and timing of start of therapy to prevent preterm labor in risky women
Conditions
- Preterm Labor
Interventions
- DRUG
-
17 alpha hydroxyprogestrone caproate
250 mg of 17 alpha hydroxyprogestrone caproate weekly
- DRUG
-
Vaginal progesterone
200 mg of vaginal progesterone daily
- DRUG
-
Oral dydrogesterone
2 tablets of dydrogesterone daily
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Principal Investigators
-
Mohamed Samy, MD · M Samy
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2018-07-31
- Completion
- 2018-08-31
Countries
- Egypt
Study Locations
More Related Trials
-
Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix
NCT02338830 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Progesterone for Prevention of Preterm Birth
NCT01180296 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery
NCT00331695 ·Status: COMPLETED ·Phase: PHASE4
-
The Use of Progesterone to Reduce Preterm Birth
NCT00830765 ·Status: COMPLETED ·Phase: NA
-
Comparing IM vs. Vaginal Progesterone for Pre-term Birth
NCT00579553 ·Status: COMPLETED ·Phase: NA
-
Vaginal Progesterone for the Prevention of Preterm Birth in Women With Arrested Preterm Labor
NCT01840228 ·Status: TERMINATED ·Phase: NA
-
Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth
NCT02913495 ·Status: COMPLETED ·Phase: PHASE4
-
17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa
NCT03779438 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate
NCT00141908 ·Status: COMPLETED ·Phase: PHASE2
-
Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation
NCT03781674 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone
NCT01317225 ·Status: UNKNOWN ·Phase: PHASE3
-
17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor
NCT00809939 ·Status: UNKNOWN ·Phase: PHASE3
-
Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa
NCT03779451 ·Status: UNKNOWN ·Phase: NA
-
Vaginal Progesterone 400mg v.s 200mg for Prevention of Preterm Labor in Twin Pregnancies
NCT04748562 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm Labor
NCT02262481 ·Status: COMPLETED ·Phase: NA
-
Progesterone to Prevent Preterm Delivery
NCT03428685 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?
NCT00329914 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor
NCT02989519 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate
NCT00120640 ·Status: WITHDRAWN ·Phase: NA
-
Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery
NCT00457886 ·Status: COMPLETED
-
Vaginal Progesterone to Reduce the Risk of Another Preterm Birth
NCT00086177 ·Status: COMPLETED ·Phase: PHASE3
-
17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies
NCT00163020 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Vaginal Progesterone Against a Second Attack of Antepartum Haemorrhage in Placenta Previa Women
NCT04725929 ·Status: COMPLETED
-
RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix
NCT00439374 ·Status: TERMINATED ·Phase: PHASE3
-
Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Short Cervix and History of PTL and/or MTM
NCT02673359 ·Status: UNKNOWN ·Phase: PHASE4